Subject

Annexin

H2A.X

DNA-X

ROS

NO

Live cells

P13

EGFR

Ki67

MAPK

BCL-2

S#1 B 13 d

25%

29%

14.8%

0.6%

4.2%

0.11

8%

5.3%

3.8%

4.8%

2.5%

C 18 d

23.3%

33.6%

10.5%

0%

4.9%

0.22

6%

4.4%

2.7%

3.4%

1.1%

C-PF 18 d

12.2%

17.5%

10.5%

0.1%

4.1%

0.48

3.1%

2%

2%

2%

0.4%

G18 d

30.3%

48.3%

10.7%

0%

12.7%

0.08

6.3%

3.4%

5.3%

8.9%

5.2%

G-PF 18 d

2.7%

17%

13.9%

0.3%

9.6%

0.25

1%

0.8%

1.8%

1.3%

3.1%

S#5 B 20 d

8.4%

11.9%

5.6%

0.1%

2.8%

0.11

3.8%

2.4%

2.8%

1.6%

1.9%

C 25 d

6.2%

24.5%

20.9%

0.2%

12.6%

0.09

5.1%

2%

3.3%

9.7%

7.2%

C-PF 25 d

1.8%

14.9%

16.4%

0.1%

1.3%

0.21

0.8%

0.5%

1.1%

2%

1.9%

G 25 d

7.2%

37.8%

27.3%

0.6%

14.6%

0.15

7.6%

4.2%

2.1%

7.1%

4.9%

G-PF 25 d

3.8%

29.4%

29.8%

0%

9.6%

0.18

5.4%

1.2%

1.9%

4.2%

1.8%

S#6 B 8 d

27%

59.2%

0.23

11.6%

0.9%

C 11 d

40.1%

81.4%

0.19

16.2%

5.8%

G 11 d

43.1%

81.3%

0.09

21.5%

8.8%

G-PF 11 d

44%

40.7%

0.27

2.8%

2%

C 14 d

57.6%

75.6%

0.08

25.5%

17.4%

G 14 d

72.3%

89.5%

0.05

34.4%

19.2%

G-PF 14 d

24.6%

36.1%

0.22

5.5%

3.7%